Neoplastic wounds: Basics of nursing care

Heridas neoplásicas: Aspectos básicos del cuidado de enfermería

Neoplastic wounds are related to the tumor and require a special and more careful approach for the different factors associated with cancer. Problems of difficult handling can be found such as bad odor, exudate, bleeding, pain, infection, visual appearance that causes low self-esteem and social isolation that leads to a marked deterioration in the quality of life of patients and their families. Objective: to determine what are the basic aspects of nursing care in neoplastic wounds. Materials and methods: this documentary review analyzes the epidemiology, classification, assessment instruments and current care interventions that the nursing professional should have when providing care to these patients. Conclusion: a multidisciplinary team is required for the management of neoplastic wounds. The problems or needs must be identified, according to this a personalized management plan will be designed and the interventions will be evaluated, generating a positive impact on the current and future lifestyle of the patient.

1. Tejada Domínguez FJ, Ruiz Domínguez MR. Heridas y fistulas tumorales: posicionamiento para mejorar el cortejo sintomático. Hygia. 2010; 74: 55-62.

2. Thomas S. Current practices in the management of fungating lesions and radiotherapy damaged skin. Bridgend, Mid Glamorgan: The Surgical Materials Testing Laboratory; 1992.

3. Probst S, Arber A, Faithfull S. Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs. 2009; 13 (4): 295-98.

4. Lo SF, Hu WY, Hayter M, Chang SC, Hsu MY, Wu LY. Experiences of living with a malignant fungating wound: a qualitative study. J Clin Nurs. 2008; 17(20): 2699-2708.

5. Grocotta P, Gethin G, Probst S. Malignant wound management in advanced illness: new insights. Curr Opin Support Palliat Care. 2013; 7(1):101-5.

6. Muñoz Rodríguez A, Escanciano Pérez I, Ballesteros Úbeda MV, Polimón Olibarrieta I, Díaz Ramírez C, González Sánchez J, et al. Manual de protocolos y procedimientos en el cuidado de las heridas [monografía en Internet]. Madrid, España: Hospital Universitario de Móstole; 2011 [citado 2015 Marzo 09]. Disponible en: http://gneaupp.info/wp-content/uploads/2014/12/manual-de-protocolos-y-procedimientos-en-el-cuidado-de-las-heridas.pdf.

7. Astudillo W, Orbegozo A, Latiegi A. Cuidados paliativos en Enfermería. San Sebastian: Sociedad Vasca de Cuidados Paliativos; 2003.

8. Torra JE, Arboix M, Soldevilla JJ, Rueda J, Segovia T, Martínez F, Torres de Castro OG. En: Soldevilla JJ, Torra JE. Atención integral de las heridas crónicas. 1a ed. Madrid: Spanish Publishers Associates; 2004.

9. Alexander SJ. An intense and unforgettable experience: the lived experience of malignant wounds from the perspectives of patients, caregivers and nurses. Int Wound J. 2010; 7(6): 456-65.

10. Delgado García JM. Valoración, identificación y evaluación de las heridas crónicas. ENE. [serie en internet]. 2013 [citado 09 Mar 2015]; 7(2): [aprox. 2 p.]. Disponible en: http://ene-enfermeria.org/ojs/index.php/ENE/article/view/311.

11. Browne N, Grocott P, Cowley S, Cameron J, Dealey C, Keogh A, et al. Wound care research for appropriate products (WRAP): validation of the TELER method involving users. Int J Nurs Stud. 2004; 41(5):559-71.

12. Grocott P. Developing a tool for researching fungating wounds. [monografía en Internet]. London, Inglaterra: World Wide Wounds; 2001 [cited 2013 Nov 10]. Disponible en: http://www.worldwidewounds.com/2001/july/Grocott/Fungating-Wounds.html

13. EWMA. Position document: wound bed preparation in practice. [monografía en Internet]. London, Inglaterra: European Wound Management Association; 2004 [cited 2015 Mar 09]. Disponible en: http://ewma.org/fileadmin/user_upload/EWMA/pdf/Position_Documents/2004/pos_doc_English_final_04.pdf.

14. Grocott P. Evaluation of a tool used to assess the management of fungating wounds. J Wound Care. 2001; 6: 421-24.

15. Nocent Schulz VN. The development of a malignant wound assessment tool. [dissertation]. Canada: University of Alberta. Dept. of Public Health Sciences; 2001.

16. Lo SF, Hayter M, Hu WY, Tai CY, Hsu MY, Li Y. Symptom burden and quality of life in patients with malignant fungating wounds. J Adv Nurs. 2012; 68(6): 1312-21.

17. Lo SF, Hu WY, Hayter M, Chang SC, Hsu MY, Wu LY. Experiences of living with a malignant fungating wound: a qualitative study. J Clin Nurs. 2008; 17(20): 2699-708.

18. Lotem M. Skin problems in palliative medicine. In: Geoffrey Hanks NI, Cherny NA, ChristakisMF, Stein K,Russell KP. Oxford textbook of palliative medicine. 3rd ed. New York: Oxford University Press; 2003. p. 618-38.

19. Gfocott P. Care of patients with fungating malignant wounds. Nurs Stand. 2007; 21(24):57-8.

20. Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K. Dimethyl trisulfide as a characteristic odor associated with fungating cancer wounds. Biosci Biotechnol Biochem. 2009; 73(9): 2117-20

21. Woo K, Sibbald G, Fogh K, Glynn C, Krasner D, Leaper D, et al. Assessment and management of persistent (chronic) and total wound pain. Int Wound J. 2008; 5(2):205-15.

22. Caicedo González R. Castañeda Robles C, Cossío Gómez F, Delgado Uría A, Fernández Saíz B, Gómez España MA, et al. Manual de prevención y cuidados locales de heridas crónicas. [monografía en Internet]. Cantabria, Santander: Servicio Cántabro de Salud; 2011 [citado 10 Mar 2015]. Disponible en: http://gneaupp.info/wp-content/uploads/2014/12/prevencion-de-cuidados-locales-y-heridas-cronicas.

23. Naylor W. Assessment and management of pain in fungating wounds. Br J Nurs. 2001; 10(22 Suppl):S33-6, S38, S40.

24. Gabay M. Absorbable hemostatic agents. Am J Health Syst Pharm. 2006; 63(13), 1244–53.

25. Grocott P. Palliative management of fungating malignant wounds. J Community Nurs. 2000; 14 (3): 31-40.

26. Collier M. Management of patients with fungating wounds Collier. Nurs Stand. 2000; 15(11):46-52